ZCT Stock Chart & Stats
C$0.19
--
Market closed
C$0.19
--
Day’s Range― - ―
52-Week RangeC$0.11 - C$0.28
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.99K
Market Cap
C$1.61M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.22
Next Earnings
Aug 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding10,723,414
10 Day Avg. Volume400
30 Day Avg. Volume1,990
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Zero Candida Technologies Inc. News
ZCT FAQ
What was Zero Candida Technologies Inc.’s price range in the past 12 months?
Zero Candida Technologies Inc. lowest stock price was C$0.11 and its highest was C$0.28 in the past 12 months.
What is Zero Candida Technologies Inc.’s market cap?
Zero Candida Technologies Inc.’s market cap is C$1.61M.
When is Zero Candida Technologies Inc.’s upcoming earnings report date?
Zero Candida Technologies Inc.’s upcoming earnings report date is Aug 28, 2026 which is in 22 days.
How were Zero Candida Technologies Inc.’s earnings last quarter?
Currently, no data Available
Is Zero Candida Technologies Inc. overvalued?
According to Wall Street analysts Zero Candida Technologies Inc.’s price is currently Overvalued.
Does Zero Candida Technologies Inc. pay dividends?
Zero Candida Technologies Inc. does not currently pay dividends.
What is Zero Candida Technologies Inc.’s EPS estimate?
Zero Candida Technologies Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zero Candida Technologies Inc. have?
Zero Candida Technologies Inc. has 10,723,414 shares outstanding.
What happened to Zero Candida Technologies Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Zero Candida Technologies Inc.?
Currently, no hedge funds are holding shares in TSE:ZCT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Zero Candida Technologies Inc.
Zero Candida is focused on commercial exploitation of a number of patents and patent applications with respect to an AI smart tampon-like device, designed to treat Candidiasis and transfer the medical information via Wi-Fi to the doctor. ZC technology is a combination of a therapy light source with a selected wavelength and intensity and a transparent gel-based drug delivery system to maintain the optimum Ph level in the vagina. The device when used overnight, demonstrated a 99.9999% Candidiasis elimination in the vagina within 3 nights. ZC developed a first prototype of its device in May of 2022 and immediately commenced its first laboratory tests as a "proof of concept". In September 2023 ZC completed its pre-clinical animal studies and subsequently developed a protype (1st series) and commenced its validation. ZC is currently in the process of developing the design of its device and continues pre-clinical animal studies.
Technical Analysis
Imaging Dynamics
―
Salona Global Medical Device
―
MedX Health
―
Verisante Technology
―
NuGen Medical Devices Inc
―